ELDN
Eledon Pharmaceuticals Inc
2.70$
-5.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.8% | 98.8% | 99.3% | 90.9% | 83.8% | 91.2% | 58.6% | 51.8% | 64.1% | 44.6% | 81.0% | 80.3% | |
| 97.7% | 35.3% | 78.0% | 82.5% | 76.2% | 80.4% | 57.9% | 49.7% | 60.8% | 3.7% | 11.6% | 13.5% | |
| 97.7% | 94.1% | 92.1% | 82.5% | 76.2% | 80.4% | 57.9% | 49.7% | 60.8% | 40.6% | 79.0% | 78.9% | |
| – | – | – | – | 3.5% | 2.2% | 0.1% | – | – | – | – | 0.3% | |
| – | – | – | – | – | 8.1% | 0.7% | – | – | – | – | – | |
| – | – | 0.1% | 0.1% | 0.1% | 2.9% | 0.1% | 0.5% | – | – | – | – | |
| – | – | – | 8.9% | 11.0% | 0.0% | 24.7% | 28.5% | 0.0% | – | – | – | |
| – | – | – | – | – | – | 16.4% | 19.0% | 34.9% | 25.7% | 18.3% | 19.2% | |
| 3.9% | 9.2% | 9.8% | 6.9% | 14.9% | 13.4% | 3.3% | 3.8% | 9.3% | 33.7% | 33.4% | 52.0% | |
| 3.9% | 9.1% | 9.5% | 6.9% | 14.9% | 12.1% | 1.3% | 2.6% | 7.0% | 3.1% | 6.5% | 10.9% | |
| – | – | 11.6% | – | – | 1.6% | 0.1% | 0.2% | 0.4% | 0.3% | 0.2% | 0.2% | |
| 0.7% | 1.8% | 1.1% | 2.0% | 4.0% | 3.0% | 0.7% | 1.1% | 2.4% | 0.8% | 3.3% | 2.1% | |
| 96.1% | 90.8% | 90.2% | 93.1% | 85.1% | 86.6% | 96.7% | 96.2% | 90.7% | 66.3% | 66.6% | 48.0% | |
| -80.1% | -193.4% | -569.2% | -131.7% | -244.2% | -526.8% | -40.8% | -67.4% | -218.6% | -193.2% | -200.4% | -237.4% | |
| 0.7% | 3.7% | 14.0% | 22.4% | 52.9% | 107.9% | 7.7% | 8.7% | 15.4% | 19.6% | 27.4% | 48.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.